Poorly Differentiated Neuroendocrine Carcinomas
📧 Sign up to get email alerts when something new happens for Poorly Differentiated Neuroendocrine Carcinomas.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-02-28Clinical Trial Update: Lurbinectedin Monotherapy in Participants With Advanced or Metastatic Solid Tumors [Phase 2]
Phase 2 trial of lurbinectedin as monotherapy in participants with advanced or metastatic solid tumors was terminated; results have been pos…